SCHEMBL1717064

SCHEMBL1717064

COC[N+]1(C)CCCC1.F[B-](F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.45
LMNA P02545 1/20 0.31
KMT2A Q03164 1/20 0.31
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL907377 0.98 KDM4E (0.43) KDM4ELMNAKMT2A
SCHEMBL1769763 0.98 KDM4E (0.48) KDM4ELMNAKMT2ATP53
SCHEMBL907435 0.94 KDM4E (0.41) KDM4E
SCHEMBL907376 0.91 KDM4E (0.42) KDM4E
SCHEMBL1598394 0.90
Fluoride Ion SCHEMBL907407 0.87 KDM4E (0.50) KDM4ELMNAKMT2ATP53
Hydrochloric Acid SCHEMBL907479 0.87 KDM4E (0.50) KDM4ELMNAKMT2ATP53
SCHEMBL2099455 0.87 KDM4E (0.56) KDM4ELMNAKMT2ATP53
Water SCHEMBL1769874 0.87 KDM4E (0.50) KDM4ELMNAKMT2ATP53
SCHEMBL28908248 0.87 KDM4E (0.50) KDM4ELMNAKMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116171287-B Method for producing iodine-containing compound, and iodine-containing compound AGC株式会社 2024-04-02 CN disclosed
EP-4261205-A1 TELLURIUM-CONTAINING COMPOUND, POLYMER, AND METHOD FOR PRODUCING POLYMER AGC INC. (JP) 2023-10-18 EP disclosed
US-20230312771-A1 TELLURIUM-CONTAINING COMPOUND, POLYMER, AND METHOD FOR PRODUCING POLYMER AGC Inc. (JP) 2023-10-05 US disclosed
CN-116601144-A Tellurium-containing compound, polymer and method for producing polymer AGC株式会社 2023-08-15 CN disclosed
EP-4212553-A1 METHOD FOR PRODUCING IODINE-CONTAINING COMPOUND, AND IODINE-CONTAINING COMPOUND AGC INC. (JP) 2023-07-19 EP disclosed
US-20230203215-A1 METHOD FOR PRODUCING IODINE-CONTAINING COMPOUND, AND IODINE-CONTAINING COMPOUND AGC Inc. (JP) 2023-06-29 US disclosed
CN-116171287-A Method for producing iodine-containing compound, and iodine-containing compound AGC株式会社 2023-05-26 CN disclosed
WO-2022054547-A1 METHOD FOR PRODUCING IODINE-CONTAINING COMPOUND, AND IODINE-CONTAINING COMPOUND AGC株式会社 2022-03-17 WO disclosed
WO-2021161851-A1 METHOD FOR PRODUCING IODINE-CONTAINING COMPOUND, AND POLYMER AGC株式会社 2021-08-19 WO disclosed
WO-2021161852-A1 FLUORINE-CONTAINING POLYMER AND METHOD FOR PRODUCING SAME AGC株式会社 2021-08-19 WO disclosed
US-20100118469-A1 ELECTROLYTE SOLUTION FOR ELECTRIC DOUBLE LAYER CAPACITOR OTSUKA CHEMICAL CO., LTD. 2010-05-13 US disclosed
EP-2172463-A1 Quaternary ammonium salt, electrolytic solution and electrochemical device Otsuka Chemical Co., Ltd. (JP) 2010-04-07 EP disclosed
US-20100044617-A1 Method for producing high-purity quaternary ammonium salt STELLA CHEMIFA CORPORATION (JP) 2010-02-25 US disclosed
US-20090309060-A1 Additives for Electrolyte Solution and Electrolyte Solution OTSUKA CHEMICAL CO., LTD. (JP) 2009-12-17 US disclosed
US-20090272933-A1 Process for production of highly pure quaternary ammonium salt STELLA CHEMIFA CORPORATION (JP) 2009-11-05 US disclosed
EP-2098518-A1 PROCESS FOR PRODUCTION OF HIGHLY PURE QUATERNARY AMMONIUM SALT Otsuka Chemical Co., Ltd. (JP) 2009-09-09 EP disclosed
EP-2072496-A1 METHOD FOR PRODUCING HIGH-PURITY QUATERNARY AMMONIUM SALT Otsuka Chemical Co., Ltd. (JP) 2009-06-24 EP disclosed
EP-2037468-A1 ADDITIVE FOR ELECTROLYTE SOLUTION AND ELECTROLYTE SOLUTION Otsuka Chemical Co., Ltd. (JP) 2009-03-18 EP disclosed
US-20070042271-A1 Quaternary ammonium salt, electrolyte, and electrochemical device OTSUKA CHEMICAL CO., LTD. (JP) 2007-02-22 US disclosed
EP-1642894-A1 QUATERNARY AMMONIUM SALT, ELECTROLYTE, AND ELECTROCHEMICAL DEVICE OTSUKA CHEMICAL COMPANY, LIMITED (JP) 2006-04-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090309060-A1 Additives for Electrolyte Solution and Electrolyte Solution SLC9A1, SLC26A3, AQP1 KDM4E 1133/4885LMNA 568/4885KMT2A 1260/4885
US-20070042271-A1 Quaternary ammonium salt, electrolyte, and electrochemical device DNMT3A, NHERF1, SLC9A1 KDM4E 448/4885LMNA 2823/4885KMT2A 268/4885
US-20230203215-A1 METHOD FOR PRODUCING IODINE-CONTAINING COMPOUND, AND IODINE-CONTAINING COMPOUND SSTR2, TPO, BRI3BP KDM4E 4365/4885LMNA 4203/4885KMT2A 1860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.